Effective Treatment of Sleep Apnea in Prediabetes to Reduce Cardiometabolic Risk
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
Although obstructive sleep apnea (OSA) is associated with impaired glucose tolerance and
diabetes, it remains unclear whether OSA treatment with continuous positive airway pressure
(CPAP) has metabolic benefits. The objective of this study is to determine the effect of
8-hour nightly CPAP treatment on glucose metabolism in individuals with prediabetes and OSA.